schizophrenia
Overview of Long-Acting Injectable Schizophrenia Medications
Long-acting injectable antipsychotics are an important treatment option for patients with schizophrenia.
JUNE 7, 2024
Introducing the S.C.O.P.E. Educational Platform for Long-Acting Injectable Antipsychotics
To alleviate knowledge gaps and clarify the role of long-acting injectable antipsychotic agents for schizophrenia, ...
SEPTEMBER 18, 2023
Early Identification and Treatment for Schizophrenia Is Crucial, Expert Says
A person’s first episode of schizophrenia offers the greatest opportunity for effective treatment, an expert ...
SEPTEMBER 18, 2023
Side Effects, Tolerability Are Top Considerations for Prescribing LAI Antipsychotics
Side effects and tolerability ranked as the most important clinical concerns for psychiatric clinicians selecting a ...
SEPTEMBER 18, 2023
FDA Approves Perseris for Schizophrenia
The FDA approved the use of Perseris, a risperidone-containing long-acting injectable for treating schizophrenia.
JULY 30, 2018
FDA Approves New Indication for Vraylar
Herbert Meltzer, MD: “Schizophrenia is one of the most challenging mental health disorders to manage, ...
NOVEMBER 15, 2017
FDA Approves Pill That Can Track Whether Patients Took the Med
The size of a grain of rice, the new Abilify MyCite has an ingestible sensor embedded in the pill that records that ...
NOVEMBER 14, 2017
More Not Better When Prescribing Antipsychotics
Multiple antipsychotic meds can cause serious adverse events—without improving outcomes for patients.
JULY 20, 2016
